Cargando…
Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
Metastatic non-small cell lung cancer (NSCLC) is associated with a limited survival when treated with palliative intent platinum-based chemotherapy alone. Recent advances in imaging and therapeutic strategy have identified a subset of patients with limited metastases who may benefit from early local...
Autores principales: | Wujanto, Caryn, Vellayappan, Balamurugan, Siva, Shankar, Louie, Alexander V., Guckenberger, Matthias, Slotman, Ben J., Onishi, Hiroshi, Nagata, Yasushi, Liu, Mitchell, Lo, Simon S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863405/ https://www.ncbi.nlm.nih.gov/pubmed/31799188 http://dx.doi.org/10.3389/fonc.2019.01219 |
Ejemplares similares
-
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019) -
Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020) -
Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016) -
A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?
por: Al-Shafa, Faiez, et al.
Publicado: (2019) -
Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
por: Mazzola, Rosario, et al.
Publicado: (2019)